Date
November 8, 2024
Topic
Hepatocellular Carcinoma (HCC)
Organised by ESGAR and it's affiliated societies:
ASAR, ARGANZ, SAR
Organising Committee
Dr. Damian Tolan, Leeds, United Kingdom
Organising Committee Chair
Prof. Giuseppe Brancatelli, Palermo, Italy
Scientific Coordinator
Prof. Valerie Vilgrain, Clichy, France
Scientific Coordinator
Dr. Marc Zins, Paris, France
ESGAR President
Live Streaming
The virtual forum will be live streamed in a Zoom Webinar format. The session times are CET (Central European Time).
The forum will be broadcast live from 12:00 noon to 18:00 CET, featuring live translations and subtitles in Spanish, French, Portuguese and simple Chinese.
Description
This forum represents a noteworthy collaborative effort between ESGAR and its affiliated societies in Asia (ASAR), Australia/New Zealand (ARGANZ), and North America (SAR), aimed at advancing the field of Radiology.
This one-day global virtual event is dedicated to Hepatocellular Carcinoma (HCC), the commonest abdominal malignancy. The agenda encompasses a comprehensive exploration of HCC, including discussions on its global impact and burden, pathophysiology, multimodality imaging assessment for screening, staging, and treatment response evaluation, as well as systemic and interventional radiology image-guided therapies. Distinguished speakers from all five continents will contribute to deepening your understanding of abdominal imaging and foster a spirit of international collaboration among radiologists to improve the lives of patients, as detailed in the programme.
Programme
November 8, 2024
12:00 – 13:00 | Session 1: The Worldwide Burden of Hepatocellular Carcinoma | Moderators: Damian Tolan, Leeds/UK; |
| 12:00 – 12:10 | The global burden of HCC: International trends and perspectives | Harriet Rumgay, WHO, Geneva/CH |
| 12:10 – 12:20 | Barriers to implementation and access to care | Danjuma K. Adda, WHA, NG |
| 12:20 – 12:30 | Screening and surveillance for HCC: Who, when and how | Valérie Vilgrain, Clichy/FR |
| 12:30 – 12:40 | Hepatocarcinogenesis and molecular characterisation of HCC: Rad-path correlation | Jessica Yang, Sydney/AU |
| 12:40 – 12:50 | The role of diagnostic and interventional radiologists in the multidisciplinary meetings | James Seow, Perth/AU |
| 12:50 – 13:00 | Discussion |
| 13:30 – 14:30 | Session 2: Optimising multi-modality imaging in liver disease (Ultrasound, CT and MRI) | Moderators: Cher Heng Tan, Singapore/SG; |
| 13:30 – 13:42 | Liver imaging: Optimising my Ultrasound approach | Paul Sidhu, London/UK |
| 13:42 – 13:54 | Liver imaging: Optimising my CT protocol | Daniella Braz Parente, Rio de Janeiro/BR |
| 13:54 – 14:06 | Liver imaging: Optimising my MRI protocols | Frank Miller, Chicago, IL/US |
| 14:06 – 14:18 | Liver imaging: Quantification techniques | Manuela França, Porto/PT |
| 14:10 – 14:30 | Discussion |
15:00 – 16:00 | Session 3: Diagnosis and staging of hepatocellular carcinoma | Moderators: Marc Zins, Paris/FR; |
| 15:00 – 15:12 | Diagnosis and staging of hepatocellular carcinoma: Western guidelines | Christoph J. Zech, Basel/CH |
| 15:12 – 15:24 | Diagnosis and staging of hepatocellular carcinoma: Eastern guidelines | Jeong Min Lee, Seoul/KR |
| 15:24 – 15:36 | Ultrasound and CEUS for HCC diagnosis – my 3 top points | Stephanie Wilson, Calgary, AB/CA |
| 15:36 – 15:48 | How to use CT/MRI LI-RADS: Looking backward to look forward | Victoria Chernyak, New York, NY/US |
| 15:48 – 16:00 | Discussion |
16:30 – 17:30 | Session 4: Additional key imaging concepts in HCC management | Moderators: Alice W. Fung, Portland, OR/US; |
| 16:30 – 16:40 | How to deal with premalignant lesions in daily practice: A case-based session | Maxime Ronot, Clichy/FR |
| 16:40 – 16:50 | Interventional radiology and image-guided treatments for HCC | Charles Sanyika, Johannesburg/ZA |
| 16:50 – 17:00 | Systemic therapy in advanced HCC: What every radiologist needs to know | Bachir Taouli, New York, NY/US |
| 17:00 – 17:10 | Evaluating treatment response in HCC | Jin Wang, Guangzhou/CN |
| 17:10 – 17:20 | CT/MRI v2024 and CEUS v2024 treatment response assessment: What’s new in LI-RADS? | Claude Sirlin, San Diego, CA/US |
| 17:20 – 17:30 | Discussion |
Registration
To overcome geographical and economic barriers in medical education, the programme from the leading international experts is free of charge for all participants.
Speakers
| Danjuma K. Adda World Hepatitis Alliance (WHA) Nigeria | James Seow Royal Perth Hospital Perth, Australia |
| Giuseppe Brancatelli University of Palermo Palermo, Italy | Paul Sidhu King's College London London, United Kingdom |
| Victoria Chernyak Memorial Sloan Kettering Cancer Center New York, NY, United States of America | Claude Sirlin University of California San Diego, CA, United States of America |
| Harriet Rumgay World Health Organisation (WHO) Geneva, Switzerland | Bin Song West China Hospital Sichuan University Chengdu, China |
| Manuela França Centro Hospitalar do Porto Porto, Portugal | Cher Heng Tan Tan Tock Seng Hospital Singapore |
| Alice W. Fung Oregon Health & Science University Portland, OR, United States of America | Bachir Taouli Mount Sinai Hospital New York, NY, United States of America |
| Mark Goodwin Austin Health Melbourne, Australia | Damian Tolan Leeds Teaching Hospital NHS Leeds, United Kingdom |
| Jeong Min Lee Seoul National University Hospital Seoul, South Korea | Valerie Vilgrain Hôpital Beaujon Clichy, France |
| Kate McLean Princess Alexandra Hospital Brisbane, Australia | Jin Wang Jinan University Guangzhou, China |
| Frank Miller Northwestern University Chicago, IL, United States of America | Stephanie Wilson University of Calgary Calgary, AB, Canada |
| Daniella Parente Federal University of Rio de Janeiro Rio de Janeiro, Brazil | Jessica Yang Macquarie University Hospital and St Vincent's Private Hospital Sydney, Australia |
| Maxime Ronot Hôpital Beaujon Clichy, France | Christoph Johannes Zech University Hospital Basel Basel, Switzerland |
| Charles Sanyika Wits University Donald Gordon Medical Centre Johannesburg, Gauteng, South Africa | Marc Zins Hôpital Saint Joseph Paris, France |